Latest Conference Articles

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new subgroup analysis from the phase 3 CREDENCE study,

The literature review indicated that there was a significant need for human trafficking (HT) training within emergency departments (ED) and pharmacy school curriculum.

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, Associate Professor, Midwestern University College of Pharmacy – Glendale, Glendale, AZ, discusses management of anticoagulation medications in special populations, including pregnant women and elderly individuals.

The award honors outstanding individuals who have made major contributions to pharmacy practice.

At the ASHP Summer Meeting in Boston, Michael Botticelli, of the Grayken Center for Addiction at Boston Medical Center, looked at factors that helped create this crisis.

Ali McBride, PharmD, BCOP, president of the Association of Community Cancer Centers, discusses how pharmacists can assist in adverse event management during the American Society of Clinical Oncology Annual Meeting in Chicago, IL

Ali McBride, PharmD, BCOP, president of the Association of Community Cancer Centers, discusses the key takeaways from the ASCO 2019 meeting and the important information that pharmacists should be aware of during the American Society of Clinical Oncology Annual Meeting in Chicago, IL

Thomas Pierson, PharmD, MS, Manager, Specialty Clinics, Cleveland Clinic, Cleveland, OH, discusses the importance of taking on challenges in ambulatory care pharmacy and utilizing the different strengths of care team members.

In recent years, diabetes technology has evolved at a rapid pace.

Hospital pharmacists are encouraged to play a larger role for improving patient outcomes.

Data from 2 studies noted no differences between either program.

Thomas Pierson, PharmD, MS, Manager, Specialty Clinics, Cleveland Clinic, Cleveland, OH, discusses reimbursement payment issues for pharmacists in the ambulatory care setting. This video was filmed at the 2019 American Society of Health-System Pharmacists (ASHP) Summer Meeting in Boston.

Researchers did not find a statistically significant benefit in using vitamin D to decrease the likelihood of developing type 2 diabetes in high risk individuals.

A large gathering of clinical pharmacists, this meeting runs June 8-12 at the Hynes Convention Center.

Ginah Nightingale, PharmD, BCOP, associate professor of pharmacy practice at the Jefferson College of Pharmacy at Thomas Jefferson University discusses how pharmacist-led interventions help to reduce adverse events associated with polypharmacy in geriatric patients during the American Society of Clinical Oncology Annual Meeting in Chicago, IL.

Jorge Eduardo Cortes, MD, Deputy Chair and Professor of Medicine in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas, references the ENESTop 192-week study results in which treatment-free remission was achieved in patients with chronic myeloid leukemia in chronic phase after stopping second-line nilotinib.

Ginah Nightingale, PharmD, BCOP, associate professor of pharmacy practice at the Jefferson College of Pharmacy at Jefferson University, discusses how pharmacists can counsel geriatric patients who may be taking multiple medications for chronic illnesses during the American Society of Clinical Oncology Annual Meeting in Chicago, IL.

The Impassion130 trial evaluated whether atezolizumab plus nanoparticle albumin-bound paclitaxel increased overall survival in patients with triple negative breast cancer when compared to chemotherapy alone.

During the American Society of Clinical Oncology Annual Meeting in Chicago, IL, Ali McBride, PharmD, BCOP, president of the Association of Community Cancer Centers, discusses how growth in the oncology space will affect how pharmacists practice.

Jorge Eduardo Cortes, MD, Deputy Chair and Professor of Medicine in the Department of Leukemia at MD Anderson Cancer Center in Houston, Texas, discusses his recommendations for pharmacists who may be counseling a patient with chronic myeloid leukemia during the American Society of Clinical Oncology Annual Meeting in Chicago, IL.

Findings presented at the 2019 ASCO meeting show venetoclax plus obinutuzumab induced deep, high, and long-lasting minimal residual disease negativity in chronic lymphocytic leukemia.

At the 2019 American Society of Clinical Oncology Annual Meeting, Michael Atkins, MD, director at the Georgetown Lombardi Cancer Center, discussed what pharmacists should know about nivolumab/ipilimumab combination therapy in advanced melanoma.

The multi-national phase 3 clinical trial on the novel drug as a treatment option for patients with advanced bladder cancer after they’ve received standard chemotherapy and immune treatments.

Updated analysis shows favorable survival outcomes with nivolumab and ipilimumab and provides evidence of long-term survival in patients with advanced melanoma.

Researchers studied the quality of life, pain, Global Health Status, and adverse effects.

A study investigates whether a high-dose of vitamin D with or without exercise is a safe, effective option to prevent bone loss.

Expanded Medicare under the Affordable Care Act nearly eliminated racial disparities in access to timely cancer treatment between African American and white patients.

The Affordable Care Act was associated with more diagnoses of early-stage ovarian cancer and more women who received timely treatment.

To elevate the burden on many patients with HER2-positive breast cancer, investigators tested whether a targeted therapy of trastuzumab emtansine plus pertuzumab would lead to a safer option than traditional therapy.